Assistive devices: usage in patients with rheumatoid arthritis.

Clinical Rheumatology
I G de BoerTheodora P M Vliet Vlieland

Abstract

We describe the usage of various assistive devices and identify factors associated with usage in patients with rheumatoid arthritis (RA). A cross-sectional, multicentre study was performed in three outpatient rheumatology clinics in the Netherlands. Two hundred forty patients with RA participated in the study. The main measures were questionnaires and a semi-structured interview regarding the possession and usage of 21 common assistive devices in the ISO9999 categories orthopaedic footwear, personal care, mobility, household and adaptations for housing. Potential factors associated with usage included sociodemographic variables, health status, quality of life, coping strategies, self-efficacy, outcome expectations and satisfaction. Out of 240 patients, 213 (89%) had one or more assistive devices in possession (median number of devices 3.0, interquartile range 3.0). The proportions of patients never using a device in possession varied between 8% for orthopaedic insoles and 23% for grab bars. The main factors related to usage varied among categories, but common determinants were a specific impairment or disability, satisfaction with the device or related services, self-efficacy and the number of devices in possession. In conclusi...Continue Reading

References

Feb 1, 1992·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·J C Rogers, M B Holm
Feb 1, 1983·British Journal of Rheumatology·R J Haworth
Jan 1, 1994·International Journal of Technology Assessment in Health Care·U Nordenskiöld
Oct 1, 1993·Health Economics·R D HaysR M Mazel
Sep 1, 1995·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·W C MannM Tomita
Aug 1, 1996·British Journal of Rheumatology·R P RiemsmaO Wiegman
Jan 1, 1997·Disability and Rehabilitation·U Nordenskiöld, G Grimby
Sep 11, 2004·Assistive Technology : the Official Journal of RESNA·James A Lenker, Victor L Paquet
Apr 3, 2008·Arthritis and Rheumatism·Martine M VeehofMart A F J van de Laar

❮ Previous
Next ❯

Citations

Dec 15, 2010·Current Opinion in Rheumatology·Jody RiskowskiMarian T Hannan
Oct 26, 2011·Disability and Rehabilitation·Kaja PõllusteMargus Lember
Nov 26, 2015·Journal of Bodywork and Movement Therapies·Eva Swinnen, Eric Kerckhofs
May 8, 2014·Assistive Technology : the Official Journal of RESNA·James Y TungWilliam E McIlroy
Jun 10, 2016·Prosthetics and Orthotics International·Jaap J van NettenAnita Williams
Jun 26, 2010·Clinical Rehabilitation·Jaap J van NettenKlaas Postema
Mar 29, 2018·Disability and Rehabilitation. Assistive Technology·Fred A de LaatJaap J van Netten
Aug 23, 2018·Disability and Rehabilitation. Assistive Technology·Joshua R TuazonJeffrey W Jutai
Feb 2, 2018·The British Journal of Occupational Therapy·Georgia SpiliotopoulouAnne McIntyre
Feb 25, 2011·Current Opinion in Rheumatology·Theodora P M Vliet Vlieland, Cornelia H van den Ende
Jan 11, 2011·The Journal of Trauma·Bernd KinnerChristina Roll
Aug 8, 2015·Prosthetics and Orthotics International·Eva SwinnenEric Kerckhofs
Jan 11, 2017·Journal of Foot and Ankle Research·Bessie HurstNachiappan Chockalingam
May 27, 2020·European Journal of Physical and Rehabilitation Medicine·Hilde E PloegerFrans Nollet
May 7, 2014·The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association·Chien-Hsiou Liu, Shih-Chen Fan
Feb 3, 2011·Current Opinion in Rheumatology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.